FDA-Drug2026-08-19Class IIPROCESSING DEFECT

Shoolin Pharma Chem sildenafil citrate USP recalled for CGMP deviations

OTHERNationwide distributionDrugs

What this means

The FDA identified Current Good Manufacturing Practice (CGMP) deviations during an inspection of Shoolin Pharma Chem LLP, a supplier of sildenafil citrate USP—an active pharmaceutical ingredient used in prescription compounding. One lot (SDC2505001) distributed nationwide has been recalled due to these manufacturing control issues.

  • If you are a pharmacy or compounding facility that received this lot, stop using it and contact your supplier for instructions.
  • Do not dispense or compound medications using this material.
  • Report any adverse events to the FDA MedWatch program.
Get recalls like this in a free plain-English brief every Sunday.Get alerts ↓
The agency's original wording
Hazard

CGMP Deviations:Noted during FDA inspection

Intended for
Adults
Illnesses reported
None reported
Sold states
Distributed Nationwide in the USA
Affected count
25 KG, 25 X 1.00 KG bags
Manufactured in
408 B/H Ratnamani Tubes, Block/Survey No; Nr Maruti Inox, Kadi, India
Products
SILDENAFIL CITRATE USP, 1.00KG, 1.00KG-bag Net Wt. Rx only " For Prescription Compounding Only", Shoolin Pharma Chem LLP, Block/Survey no 408, B/H Ratnamani Tubes, Near Maruti Inox, Indrad, Kadi, Mahesania, Gujarat, 382715, India, (CAS NO. 171599-83-0) NDC 85702-001-08.

Official notice

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0763-2026

More Shoolin Pharma Chem recalls

Want us to check the next one for you?

We read every CPSC, FDA, USDA, and NHTSA notice and email you a plain-English Sunday brief covering your household — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.

Free · One email a week · Unsubscribe anytime
By signing up you agree to our Terms and Privacy Policy.